UK Renal Registry 20th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin in UK Adult Dialysis Patients in 2016: National and Centre-specific Analyses

In the UK in 2016: The median haemoglobin (Hb) of patients at the time of starting dialysis was 99 g/L with 47% of patients having a Hb >= 100 g/L. The median Hb in patients starting haemodialysis (HD) was 96 g/L (IQR 87-105) and in patients starting peritoneal dialysis (PD) was 108 g/L (IQR 98-116). At the start of dialysis, 50% of patients presenting early had Hb >= 100 g/L compared with only 34% of patients presenting late. The median Hb of prevalent patients on HD was 111 g/L (IQR 102-119). The median Hb of prevalent patients on PD was 111 g/L (IQR 102-120). 80% of prevalent HD patients and 79% of PD patients had Hb >= 100 g/L. 59% of prevalent HD patients and 55% of PD patients had Hb >= 100 and <= 120 g/L. The median serum ferritin in HD patients was 410 mu g/L and 94% of HD patients had a ferritin >= 100 mu g/L. The median serum ferritin in PD patients was 306 mu g/L and 88% of PD patients had a ferritin >= 100 mu g/L. In England, Wales and Northern Ireland in 2016: The median erythropoiesis stimulating agent (ESA) dose in HD patients was 7,750 IU/week. The median ESA dose in PD patients was 4,500 IU/week.